The treatment took place several months after a dental emergency where her dental bridge fell out during a live performance.
RevBio, Inc., announced that it has received investigational device exemption (IDE) approval from the FDA to conduct a multi-center randomized controlled pivotal clinical trial to use TETRANITE (R) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results